These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9397123)

  • 1. Telomerase in gynecologic cancers.
    Eltabbakh GH
    Obstet Gynecol; 1997 Dec; 90(6):1015-9. PubMed ID: 9397123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between telomere length and telomerase activity in gynecologic cancers.
    Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
    Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of telomerase activity in human cancer.
    Chen CH; Chen RJ
    J Formos Med Assoc; 2011 May; 110(5):275-89. PubMed ID: 21621148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and telomerases: intimations of immortality.
    Crocker J
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):889-90. PubMed ID: 11507350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase is not an oncogene.
    Harley CB
    Oncogene; 2002 Jan; 21(4):494-502. PubMed ID: 11850774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase: An exploration toward the end of cancer.
    Popli DB; Sircar K; Chowdhry A
    Indian J Dent Res; 2017; 28(5):574-584. PubMed ID: 29072223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase and cancer.
    Harley CB; Kim NW
    Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy resistance in ovarian cancer: new molecular perspectives.
    Coukos G; Rubin SC
    Obstet Gynecol; 1998 May; 91(5 Pt 1):783-92. PubMed ID: 9572231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in cancer as a diagnostic and therapeutic target.
    Kyo S; Takakura M; Inoue M
    Histol Histopathol; 2000 Jul; 15(3):813-24. PubMed ID: 10963125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Telomerase: an enzyme with multiple applications in cancer research].
    Castillo Ureta H; Barrera Saldaña HA; Martínez Rodríguez HG
    Rev Invest Clin; 2002; 54(4):342-8. PubMed ID: 12415959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
    Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
    J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of telomerase in cancer.
    Kim NW
    Eur J Cancer; 1997 Apr; 33(5):781-6. PubMed ID: 9282117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
    Healy KC
    Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.
    Ahmed A; Tollefsbol T
    J Am Geriatr Soc; 2003 Jan; 51(1):116-22. PubMed ID: 12534855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length maintenance in aging and carcinogenesis.
    Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
    Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in gynecological tumors.
    Sakamoto M; Toyoizumi T; Kikuchi Y; Okamoto A; Nakayama H; Aoki D; Yamamoto K; Hata H; Sugishita T; Tenjin Y
    Oncol Rep; 2000; 7(5):1003-9. PubMed ID: 10948330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathologic implications of telomerase].
    Santos Ruiz A; Cascales Angosto M
    An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.